McCaw, Z. R., Tian, L., Kim, D. H., & Wei, L. (2019). Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”. Ann Surg.
Styl ChicagoMcCaw, Zachary R., Lu Tian, Dae Hyun Kim, a Lee-Jen Wei. "Comment On “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”." Ann Surg 2019.
Citace podle MLAMcCaw, Zachary R., Lu Tian, Dae Hyun Kim, a Lee-Jen Wei. "Comment On “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”." Ann Surg 2019.